Amylyx Pharmaceuticals (AMLX) Net Margin (2021 - 2024)
Amylyx Pharmaceuticals (AMLX) posted quarterly Net Margin of 4011.01% for Q4 2024, down 401349.0% year-over-year from N/an in Q1 2024, and up 77.05% quarter-over-quarter from 17476.92% in Q3 2024.
Amylyx Pharmaceuticals (AMLX) Net Margin (2021 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' Net Margin history runs 4 years deep, the most recent figure standing at 4011.01% for Q4 2024.
- In Q4 2024, Net Margin fell 401349.0% year-over-year to 4011.01%; the TTM figure through Sep 2025 stood at 13557.55% (up 1368926.0% YoY), while the FY2024 annual figure was 273.1%, down 28550.0% from the prior year.
- Net Margin for Q4 2024 stood at 4011.01%, up from 17476.92% in the prior quarter.
- The five-year high for Net Margin was 22.47% in Q2 2023, with the low at 17476.92% in Q3 2024.
- The 4-year median for Net Margin is 200.17% (2022), against an average of 4780.24%.
- The sharpest annual moves came in 2023 and 2024: Net Margin jumped 1560179 bps in 2023, then tumbled 1749727 bps in 2024.
- Amylyx Pharmaceuticals' Net Margin stood at 8120.0% in 2021, then jumped by 98 bps to 200.17% in 2022, then soared by 101 bps to 2.49% in 2023, then tumbled by 161386 bps to 4011.01% in 2024.
- Business Quant data shows AMLX's Net Margin at 4011.01% in Q4 2024, 17476.92% in Q3 2024, and 7106.55% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4,011.01% |
| Sep 30, 2024 | -17,476.92% |
| Jun 30, 2024 | -7,106.55% |
| Mar 31, 2024 | -134.01% |
| Dec 31, 2023 | 2.49% |
| Sep 30, 2023 | 20.35% |
| Jun 30, 2023 | 22.47% |
| Mar 31, 2023 | 2.20% |
| Dec 31, 2022 | -200.17% |
| Sep 30, 2022 | -15,581.45% |
| Sep 30, 2021 | -8,120.00% |